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Abstract
FADD (Fas–associated death domain) and TRADD (Tumor Necrosis Factor Receptor
1-associated death domain) proteins are important regulators of cell fate in mammalian
cells. They are both involved in death receptors mediated signaling pathways and have
been linked to the Toll-like receptor family and innate immunity. Here we identify and char-
acterize by database search analysis, mutagenesis and calmodulin (CaM) pull-down as-
says a calcium-dependent CaM binding site in the α-helices 1–2 of TRADD death domain.
We also show that oxidation of CaMmethionines drastically reduces CaM affinity for FADD
and TRADD suggesting that oxidation might regulate CaM-FADD and CaM-TRADD interac-
tions. Finally, using Met-to-Leu CaMmutants and binding assays we show that both the N-
and C-terminal domains of CaM are important for binding.
Introduction
Signal transduction pathways controlling immunity, inflammation and apoptotic or necropto-
tic cell death depend to a large extent on proteins containing homotypic interaction domains
belonging to the death-fold superfamily [1, 2]. This superfamily consists of receptor, adaptor,
effector and inhibitor proteins containing protein-protein interaction modules: death domain
(DD), death effector domain (DED), caspase recruitment domain (CARD) and pyrin domain
(PYD) that characterize four subfamilies. Hallmark of the superfamily is a protein-protein in-
teraction domain structure, the so-called death-fold, which consists of a globular structure
wherein six amphipathic α-helices are arranged in an antiparallel α-helical bundle with Greek
key topology [3–6]. Variations in length and orientation of the α-helices as well as distribution
of charged and hydrophobic residues at the surface are small among members of each subfami-
ly. Death-fold domains are involved in the assembly of multimeric complexes leading to activa-
tion of key effectors such as caspases and kinases [1, 2].
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Members of the death-fold superfamily can also interact with proteins that do not belong to
the superfamily. Fas receptor and FADD, containing a DD [7, 8], and FLIP (FLICE inhibitory
protein), containing a DED [9], have been identified as calmodulin (CaM) target proteins.
CaM is a key calcium sensor protein involved in eukaryotic cells in a variety of cellular pro-
cesses including apoptosis, cell cycle, inflammation and immune response [10]. CaM is com-
posed of two globular domains, the N- and C-terminal lobes, linked by a flexible helix called
the central linker. Each domain contains two helix-loop-helix EF-hand calcium-binding motifs
[11, 12]. Upon calcium binding, CaM undergoes major conformational changes exposing hy-
drophobic target-binding surfaces in each of the globular domains [13–15]. These highly mal-
leable surfaces allow binding and regulation of numerous, structurally diverse targets [16, 17].
CaM can also bind targets in the apo or partially saturated calcium forms. CaM contains nine
highly conserved methionine residues. In mammalian CaM, four methionine residues are clus-
tered in each of the globular domains at residues 36, 51, 71, and 72 in the N-terminal domain
and at residues 109, 124, 144, and 145 in the C-terminal domain. A ninth methionine is located
in the linker region at position 76. Due to their side-chain flexibility and hydrophobicity, me-
thionine residues play important functions in Ca2+-bound CaM, stabilizing the open confor-
mation and providing a target-binding interface [18]. The importance of methionine residues
of CaM is also supported by their evolutionary conservation. For example, in Tetrahymena and
Dicytostelium, all nine methionine residues have been preserved. In Saccharomyces cerevisiae,
three methionine residues are conserved (Met 36, Met 72 and Met 124) and other six have
been replaced by leucine [19]. Methionine residues in Ca2+-CaM are surface exposed and thus
susceptible to oxidation [20]. The efficacy of several targets recognition and regulation by CaM
is modified by methionine oxidation [21–36].
We have previously identified CaM as a FADD interacting protein and two binding sites in
the C-terminal DD have been characterized [8]. FADD is a key adaptor protein transmitting
apoptotic signals mediated by death receptors. It has also been implicated in multiple non-
apoptotic functions including autophagic and necroptotic cell death, NF-kB activation, innate
immunity, proliferation and cell cycle progression [37–39]. FADD and TRADD interact with
each other and share important structural, functional features and subcellular localization. In
particular, they have a C-terminal DD, are mediators of apoptotic and survival signals and are
both involved in innate immunity pathways [40]. Here we used a database search and binding
experiments, using recombinant proteins and cell lysates of hematopoietic and non-hematopoietic
cell lines, to identify a putative CaM binding site in the α-helices 1–2 of TRADD.DD and to
show that point mutations in α-helix 2 strongly impair TRADD-CaM interaction. Further, CaM
oxidation and site-specific mutagenesis were used to show that both the N- and C-terminal lobes
of CaMmediate CaM-FADD and CaM-TRADD interactions. Using extensively (hydrogen per-
oxide, H2O2 treatment) and partially (treatment of oxidized CaM with methionine sulfoxide re-
ductases) oxidized CaM and site-directed Met-to-Leu CaMmutants for in vitro binding assays
we demonstrated that: i) oxidation of all methionine residues decreases the affinity of CaM for
both FADD and TRADD to undetectable levels; ii) methionine residues in both the N- and C-
terminal lobes of CaM are involved in the interaction of CaM with FADD and TRADD; iii) treat-
ments with both methionine sulfoxide reductases, MsrA and MsrB2, that completely repair oxi-
dized CaM, restore the interaction of CaM with both FADD and TRADD.
Material and Methods
Cells, Antibodies, and Reagents
Human cell lines, HuT78 T cell lymphoma (ATCC) and U937 monocytic/macrophage
(ATCC), were cultured in RPMI 1640 medium (BioWhittaker, Lonza, USA). Epithelial cells,
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HelaS3 and human embryonic kidney (Hek) 293T, were cultured in Dulbecco’s modified Ea-
gle’s medium, 4.5 g/L glucose. Tissue culture media were supplemented with 10 mMHepes pH
6.98–7.30, 1 mM L-glutamine, 100 U/ml penicillin/streptomycin (BioWhittaker) and heat in-
activated 5% (HelaS3, Hek 293T) or 10% (all other cell lines) fetal bovine serum. All cells were
cultured at 37°C in a 5% CO2 humidified incubator. Calmodulin sepharose 4B, protein G
sepharose fastflow, protein A sepharose CL-4B and glutathione S-transferase (GST) sepharose
4B were from GEHealthcare Europe; EZview red and anti-Flag M2 affinity gel were from Sigma-
Aldrich, Ni-NTA resin fromQiagen, Italy. Primary antibodies used were: GST goat polyclonal
antibody (GE Healthcare Europe); FADDmouse IgG1 clone A66-2 (Becton Dickinson BD Phar-
mingen) and mouse Ig1 clone 1 (BD Transduction Laboratories); calmodulin mouse IgG1 (Up-
state Biotechnology, Inc—UBI) and CaM I rabbit polyclonal (Santa Cruz Biotechnology, Inc.);
TRADDmouse IgG2a (UBI); Flag and Flag-peroxidase M2 mouse IgG1 (Sigma-Aldrich); HA
and HA-horseradish peroxidase (HRP) conjugated clone 12CA5 mouse IgG2b (Roche Applied
Science). Sheep anti-mouse and anti-rabbit immunoglobulins HRP-conjugated were purchased
from GEHealthcare Europe. CaM recombinant protein was from UBI, protease and phosphatase
inhibitors were obtained from Roche Applied Science and Sigma-Aldrich.
E. coli and mammalian expression vectors
pGEX-FADD and pEF-HA-FADD plasmids have been previously described [8]. TRADD full
length open reading frame (ORF) and TRADD deletion mutants were produced by PCR using
as template the IMAGE clone ID 3689007 and PCR fragments were cloned in pGEX expression
vector (GE Healthcare, Europe). The QuickChange site-directed mutagenesis kit (Agilent
Technologies, Inc Santa Clara, CA, USA) was used to generate point mutations in TRADD.
Wild-type and TRADDmutants coding sequences were subcloned in pCMV-Tag2B expres-
sion vector 3’ to Flag (Agilent Technologies, Inc). The pET-15b-CaM plasmid [41] was kindly
provided by Dr. M. Ikura (University Health Network, Ontario, Canada). The ORF of human
methionine sulfoxide reductase, MsrA and murine MsrB2 were produced by PCR, using as
template the Image clones 6504055 and 5150285, and cloned in the pQE-9 expression vector
(Qiagen, Italy) 3’ to the 6xHis-tag coding sequence.
Expression and purification of recombinant GST and His proteins
Recombinant GST- and His-tagged proteins were expressed and produced in BL21 (DE3)
E. coli strain. For GST fusion proteins, E. coli transformed colonies were grown in 2XYT
medium broth at 37°C until the OD600 reached 0.6–0.8, then 0.1 mM isopropyl-1-thio-{beta}-
D-galactopyranoside (IPTG) was added and cells were grown for 3 h at 30°C or 37°C. Bacteria
were lysed according to manufacturer’s directions. His-CaM protein was purified as previously
described [8]. Human His-MsrA and murine His-MsrB2 enzymes were expressed and pro-
duced in E. coli cells, transformed colonies were grown in LB medium broth at 37°C to 0.8
OD600. Then, protein expression was triggered by addition of 1 mM IPTG. After 4 h of addi-
tional growth at 30°C, the bacteria were pelleted and resuspended in 20 mM Tris-HCl, pH 8.0,
0.7 M NaCl (buffer A) containing 20 mM imidazole, and disrupted by sonication. After centri-
fugation, the supernatants were purified with a Ni-NTA resin equilibrated in buffer A contain-
ing 20 mM imidazole, pH 8.0. After washing with buffer A containing 60 mM imidazole, the
His-tagged proteins were eluted with buffer A containing 1 M imidazole.
Expression and purification of Met-to-Leu CaMmutants
Met-to-Leu CaMmutants, previously described [34], were produced by site directed mutagen-
esis of CaM. Briefly, mutants were constructed from the wild-type rat CaM cDNA by using
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primer-based site-directed mutagenesis. DNA sequence analysis confirmed the correct generation
of each mutant. Leucine was substituted for: i) all methionine (9L); ii) all but M109 (8L 109M); iii)
all but M124 (8L 124M); iv) all methionine residues in the N-terminal domain along with M76 of
the linker region (M36-76L); v) selected methionine in the C-terminal domain (M124-145L); vi-
viii) combination of N- and C-terminal methionine residues (M36-76L; M51-72L; M36/M76-
M145L) (Table 1). CaMmutants were expressed in E. coli BL21 (DE3) pLys5 strain, purified via
phenyl-sepharose chromatography and dialyzed overnight at 4°C against 2 mMHEPES (pH 7.0)
as previously described [42]. Protein concentration was determined by colorimetric assay using
wild-type CaM as protein standard. CaM concentration was determined by the published molar
extinction coefficient ε277 nm–302 nm = 3,029M
−1 cm−1 [43]. Purified CaMmutants (0.5 μg) were
loaded on 12 or 15% SDS-PAGE using Laemmli reducing sample buffer containing 1 mM EGTA.
A single protein band on coomassie blue-stained gels (*20 kDa) confirmed samples purity.
In vitro oxidation of CaMmethionines
CaM was oxidized essentially as previously described [26]. Briefly, 60 μM of purified CaM in
50 mMMES, pH 5.5, 1 mMMgCl2, 100 mM KCl, was incubated for 23 h with 50 mMH2O2 at
room temperature. To stop the oxidation reaction, sample was dialyzed at 4°C against 10 mM
sodium phosphate, pH 7.0, 100 mM KCl.
In vitro reduction of CaMmethionines by MsrA or/and MsrB2
Oxidized CaM (15 μM) in 10 mM sodium phosphate, pH 7.0, 100 mM KCl was incubated with
5 μMMsrA and/or 5 μMMsrB2 and 15 mMDTT (used as an electron donor, reducing agent)
for 30 min at 37°C. Oxidation state and reduction efficiency of CaM was verified by denaturing
15% SDS-PAGE stained with coomassie blue. Samples were loaded in Laemmli sample buffer
containing 2 mM Ca2+.
CaM and GST pull-down assays
CaM binding assays were performed as previously described [8]. Briefly, E. coli GST-proteins
or 35S-Met-labeled proteins, produced with a coupled transcription/translation kit (TnT
Table 1. Met-to-Leu CaM mutants.
CaM mutants CaM domains: Met and Leu positions
Code Description N-terminal Linker C-terminal
36 51 71 72 76 109 124 144 145
1 wild type M M M M M M M M M
2 9L L L L L L L L L L
3 8L 109M L L L L L M L L L
4 8L 124M L L L L L L M L L
5 M36–76L L L L L L M M M M
6 M124–145L M M M M M M L L L
7 M51–72L M L L L M M M M M
8 M36/76–145L L M M M L L L L L
Methionine residues located in the N-teminal (Met 36, 51, 71, 72), C-terminal (Met 109, 124, 144, 145) and linker region (Met 76) of CaM are listed. Mutant
description reflects the relative position of Met-to-Leu substitutions as schematically indicated; 9L all nine methionine mutated, 8L 109M and 8L 124M
eight methionine mutated with the exception respectively of residues 109M or 124M.
doi:10.1371/journal.pone.0116251.t001
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Coupled Reticulocyte Lysate System; Promega, Italy) according to the manufacturer’s instruc-
tions, were diluted in binding buffer (50 mM Tris-HCl pH 7.6, 120 mMNaCl, 1% Brij 98) and
incubated with calmodulin-sepharose 4B or control sepharose for 2 h at 4°C. After five washes,
interacting proteins were eluted in 1 M NaCl, 2 mM EGTA and beads were boiled in reducing
Laemmli sample buffer. Proteins were separated by SDS-PAGE and gels were either coomassie
stained and exposed to phosphorimager or blotted to Hybond C nitrocellulose membranes
(GE Healthcare, Europe) for western blot analysis. In GST pull-down assays with recombinant
His-CaM, oxidized His-CaM (CaMox), oxidized His-CaM repaired by treatment with MsrA
(CaMMsrA) or MsrB2 (CaMMsrB2) or with both MsrA and MsrB2 (CaMR), no-tagged wild-type
CaM and CaMMet-to-Leu mutants, the binding buffer was 10 mM potassium phosphate pH
7.0, 100 mM KCl and 1% Brij. In pull-down assays, 5 μg of CaM or GST proteins bound to
beads were incubated with soluble GST or CaM proteins. To analyze pull-down assays, 1/20 of
input (I) and 1/10 of eluates (E) were loaded on 12 or 15% (w/v) SDS-PAGE, if not otherwise
specified. TRADD pull-down assays with 35S-Met-labeled FADD protein was essentially per-
formed as previously described [44].
CaM overlay experiments
Blot overlay assays with Xenopus laevis biotinylated His-CaM protein were performed as previ-
ously described [8].
Cell transfection and immunoprecipitation assays
For TRADD-FADD in vivo interactions, Hek 293T cells were co-transfected with pCMV-
Tag2B-TRADD and pEF-HA-FADD plasmids by the calcium phosphate method. Cells were
harvested and lysed for 30 min on ice in lysis buffer (10 mM Tris-Cl, pH 7.4, 150 mMNaCl,
1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 0.5% Nonidet P-40, protease and phophatase in-
hibitors) as previously described [44]. For the co-immunoprecipitation (IP) of TRADDmu-
tants and FADD, 500 μg of cell extracts were incubated with Flag-resin at 4°C washed and
processed following manufacture’s protocol. Total lysates and co-IP fractions were separated
by 12% SDS-PAGE, blotted and probed with HA-HRP or Flag-HRP conjugated antibodies.
Results and Discussion
Identification of a calcium-dependent CaM binding site in TRADD
The database of Dr. Ikura’s laboratory (http://calcium.uhnres.utoronto.ca/ctdb) was used to
search for putative CaM binding sites in TRADD [16]. Computational tools assign scores to
putative binding sites within a protein sequence based on α-helical tendency, hydropathy, resi-
due weight, net charge, hydrophobic residue content and occurrence of specific residues. Scores
assigned to a twenty residues window are normalized for the entire sequence. In TRADD, three
putative CaM binding sites are predicted: one located in the N-terminal domain (aa 78–129)
and two in the C-terminal DD (aa 212–249; aa 261–289) (Fig. 1A). The most likely binding site
is highlighted by a series of 9s [16].
To demonstrate a direct binding between TRADD and CaM, to investigate whether the in-
teraction was calcium-dependent and to identify CaM binding sites in TRADD, we performed
binding assays with: i) CaM-sepharose and soluble GST-TRADD fusion proteins or 35S-Met-
labeled TRADD protein; ii) sepharose bound GST-TRADD and 35S-Met-labeled CaM protein.
Binding assays, SDS-PAGE and autoradiography analyses show that 35S-Met-TRADD specifi-
cally binds to CaM-sepharose in a calcium-dependent fashion (Fig. 1B). Intriguingly, TRADD
protein upon binding to CaM-sepharose migrates as a doublet in SDS-PAGE (Fig. 1B lane 2),
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Figure 1. Ca2+-dependent binding of CaM to TRADD. A: CaM target database analysis. Amino acid
sequences of the predicted CaM binding sites in human TRADD are shown along with the corresponding
probability scores.B: autoradiography of CaM pull-down assay. (I) shows input of 35S-TRADD (* 33 kDa)
incubated with CaM sepharose (CaM) or control sepharose (Ctrl) beads in Ca2+ or EGTA binding buffer. C:
autoradiography of pull-down assay of 35S-CaMwith GST or GST-TRADD. Panel a) shows a 12% SDS-
PAGE stained with coomassie and panel b) the corresponding autoradiogram for 35S-CaM. D: western blot of
His-CaM pull-down assays. His-CaM or His-Ctrl (control, cyclophilin) bound to Ni-NTA agarose beads were
incubated with cell lysates, as indicated. TL indicates total cell lysates. Positions of the molecular weight
standards are indicated. The data shown are representative of at least three independent experiments.
doi:10.1371/journal.pone.0116251.g001
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suggesting that post-translation modifications or SDS-resistant conformational changes are in-
duced in TRADD upon CaM-binding. In reciprocal experiments, GST-TRADD beads pull-
down 35S-Met-labeled CaM in a calcium specific manner (Fig. 1C). Importantly, binding of
TRADD to CaM was confirmed using endogenous human TRADD protein. Specifically,
TRADD in cellular extracts of hematopoietic (HuT78), epithelial (HeLaS3) and monocytic/
macrophagic (U937) cell lines are pull-down specifically with His-CaM nickel beads (Fig. 1D).
Identification and characterization of a calcium-dependent CaM binding
site in TRADD.DD
To further characterize the CaM binding sites, a series of GST-TRADD deletion mutants con-
taining the: N-terminal domain (N-TRADD), C-terminal DD (TRADD.DD), α-helices 1–3
(TRADD.DD α1–3) or 4–6 (TRADD.DD α4–6) of TRADD.DD (Fig. 2A) were incubated with
CaM-sepharose and bound proteins analyzed by western blot. The slower migrating bands in
western blots (inputs and eluates) correspond to the expected molecular weight of full-length
recombinant GST fusion proteins (GST*25kDa; GST-FADD*48kDa, GST-NTRADD
*44kDa, GST-TRADD.DD*38kDa, GST-TRADD.DDα1–3*32kDa, and GST-TRADD.
DDα4–6*32kDa), while the fast migrating bands likely correspond to degradation products.
In Fig. 2B we show that CaM-sepharose binds TRADD.DD in a calcium-dependent fashion,
but not N-TRADD; in the assays, GST-FADD and GST were, respectively, used as positive and
negative controls. Thus, in our experimental conditions, no interaction of N-TRADD with
CaM was detected even if a putative binding site, with a low score, was predicted by database
search in this domain (Fig. 1A).
The structure of TRADD.DD consists of a canonical anti-parallel six helix bundle, charac-
teristic of the DD superfamily, where α-helices-1 (L216-S225), -4 (L261-E276) and α-helices-2
(K229-G240) and -5 (L282-E291) lie on opposite side of the protein and α-helix-3 (A248-
R258) and -6 (T295-L301) are located, respectively, at the bottom and on top of the bundle
[45]. The DD putative CaM binding sites should be located respectively in the α-helices 1–2
with connecting loops (aa 212–249) and in the α-helices 4–5 with connecting loops (aa 261–
289). CaM sepharose pull-down assays with the two truncated mutants, containing α-helices
1–3 or 4–6 of TRADD.DD (Fig. 2A), demonstrated that only TRADD.DD α1–3 binds in a
Ca2+-dependent fashion to CaM (Fig. 2C). Therefore, the predicted putative binding site in α-
helices 4–5 of TRADD.DD, with a low prediction score (Fig. 1A), was not confirmed.
Ca2+-dependent CaM binding motifs have been classified by the spacing between hydro-
phobic anchor residues (http://calcium.uhnres.utoronto.ca/) given the lack of a well-defined
CaM binding consensus sequence [16]. The CaM binding site predicted in αhelices 1–3 of
TRADD.DD (aa 212–249) (Fig. 1A) contains a putative 1–16 motif with 5 basic residues and a
net charge of +5 (aa 222–237 FarsvglkwrkvgrsL) and an overlapping 1–10 motif with 4 basic
residues and a net charge of +4 (aa 228–237 LkwrkvgrsL).
Identification of TRADDmutations that interfere with TRADD-CaM
interaction
The CaM binding domain of target proteins is usually a short peptide with propensity to form
a α-helix that is hydrophobic-basic in nature [46]. In many classical Ca2+-CaM peptide com-
plexes, the peptide is anchored through interaction of hydrophobic residues to hydrophobic
CaM pockets whereas basic residues mediate electrostatic contacts with the highly acidic sur-
face of CaM. Unclassified CaM binding sites have also been described [46]. For mutagenesis
studies, we selected five residues within the predicted motifs in α-helices 1–3 of TRADD.DD:
two hydrophobic (F222 and L237) and three basic (K229, R231 and R235). A series of
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GST-TRADDmutants containing single substitutions of alanine were produced and screened
by blot overlay with biotin-labeled His-CaM. As shown in Fig. 2D, F222A and L237A TRADD
mutants bind Ca2+-CaM in a manner that is essentially comparable to wild-type TRADD
(Fig. 2D). K229A, R231A and R235A TRADDmutants, instead, dramatically reduce (R235A),
or ablate (K229A, R231A), Ca2+-CaM binding as compared to wild-type TRADD (Fig. 2D). No
signal was detected when the blots were incubated with CaM protein in a buffer containing
EGTA (data not shown). Pull-down assays confirmed that K229A, R231A and R235A muta-
tions in TRADD impair CaM binding. In fact, TRADD.K229A mutant does not bind CaM-
sepharose and TRADD.R231A and TRADD.R235A reproducibly show a weaker binding to
CaM (Fig. 2E). It is unlikely that K229A, R231A and R235A mutations induce major structural
modifications in TRADD since it has been previously reported that TRADD.R231A and
TRADD.R235A mutants can bind both TNFR1 and FADD proteins [44] and TRADD.K229A
binds 35S-Met-labeled-FADD as wild-type TRADD (Fig. 2F). To further characterize the effects
of K229A, R231A and R235A mutations, we ectopically expressed, in Hek 293T cells, Flag-
TRADDmutants along with HA-FADD wild-type protein. Transfection efficiency was similar
for all TRADD mutants and, accordingly, similar protein levels were detected in total cell ly-
sates by western blot (Fig. 2G). Co-immunoprecipitation data indicate that wild-type TRADD,
as well as TRADD.R231A, TRADD.R235A and TRADD.K229A interact with FADD (Fig. 2G).
These results demonstrate that specific mutations in TRADD that impair CaM interaction do
not alter the interaction of TRADD with FADD.
Overall, these results support the presence of a CaM binding site in the α-helix 2 of
TRADD.DD. Although we did not detect interaction of CaM with N-TRADD, we cannot ex-
clude the possibility that N-TRADD in the full-length protein might contribute to CaM-
TRADD interaction. The predicted CaM binding motifs (1–16, 1–10) in α-helices 1–3 of
TRADD.DD were not supported by our mutagenesis analysis; in fact the hydrophobic anchor
residues F227A and L237A did not alter CaM-TRADD binding. Further mutagenesis and
structural studies are needed to characterize the CaM binding motif in the α-helix 2 of
TRADD.DD.
Several members of the death-fold superfamily, containing a DD, have been identified as
CaM target proteins including Fas (CD95) receptor [7], FADD [8] and TRADD (this report).
The interaction of CaM with death-fold proteins likely requires significant conformational
changes in both proteins. It is well known that binding of Ca2+ to CaM triggers major structural
rearrangements in both N- and C-terminal lobes resulting in accessibility of hydrophobic resi-
dues that are essentially buried in apo calmodulin [13–15]. However, in order for the interac-
tion to take place also CaM interaction binding motifs in TRADD.DD and FADD.DDmust be
Figure 2. Characterization of a CaM binding site in TRADD.DD. A: schematic representation of the GST-
TRADDmutants. The N-terminal domain (N) and the Death Domain (DD) of human TRADD are indicated. B
andC: western blot with GST specific antibody of GST-TRADDmutants (top panels, I stands for inputs) and
CaM pull-down assays (bottom panels, E stands for eluates). The GST fusion proteins indicated were pull-
down with CaM-sepharose beads in binding buffer with 2 mM Ca2+ (B, C) or EGTA (B). D: CaM blot overlay
assay. E coli BL21 lysates expressing N-TRADD (lane 1) or untransformed (Ctrl) (lane 2) were used as
negative controls. Top panel a) shows the ponceau stained filter and bottom panel b) the western blot probed
with biotin-conjugated His-CaM. E: GST-TRADD pull-down assays. The GST-TRADD proteins indicated,
bound to glutathione-sepharose beads, were incubated with His-CaM in binding buffer with 2 mM Ca2+ or
EGTA. Top panel a) shows the ponceau stained filter and bottom panel b) the western blot probed with CaM
specific antibody. I indicates the input of His-CaM. F: GST-TRADD pull-down assays. Bound proteins were
analyzed by 12% SDS-PAGE and autoradiography. Panel a) shows the coomassie stained gel where I
indicates the input of 35S-FADD. Panel b) shows the corresponding autoradiogram.G: Immunoprecipitation
(IP) assay. Total lysates of Hek 293T cells expressing HA-FADD and Flag-TRADD proteins were probed with
Flag or HA monoclonal antibodies. Cell lysates were IP with Flag-resin, as described in materials and
methods. The data shown are representative of at least three independent experiments.
doi:10.1371/journal.pone.0116251.g002
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exposed. Notably, some plasticity has been reported for members of the death fold family [47].
Characterization of a crystallographic structure of Fas.DD and FADD.DD complex, containing
four Fas.DDs and four FADD.DDs assembled in a dimer of two Fas.DD:FADD.DD complex
dimers, highlighted remarkable structural changes in Fas.DD when compared to the unbound
Fas.DD [48]. In the complex Fas.DD showed a significant open transition providing binding
sites for FADD.DD, otherwise unavailable in the unbound closed form. The structural changes
observed in the crystallographic complex led to the description of a “conditional domain inter-
action”model in which, upon Fas receptor clustering the open and unstable form of Fas recep-
tors can interact and stabilize each other, making the binding sites for FADD available [48].
Notably, a FADD.DD conformational change, even if not dramatic as the opening of Fas.DD,
was also observed and suggested to be potentially involved in the amplification of the “off-on”
switch [48]. Under different experimental conditions Fas.DD predominantly interacted with
FADD.DD in a 5:5 complex without major alteration of Fas.DD structure [49, 50]. Deeper
characterizations, under physiological conditions, of the structural changes of Fas.DD and
FADD.DD in multimeric complexes upon Fas receptor activation as well as the contribution of
other interacting proteins in such complexes are very challenging.
Remarkably, conformation and free-energy studies of the CaM-Fas.DD complex revealed
that CaM binding to Fas.DD results in conformational changes of both Fas and CaM and stabi-
lization of both structures [51]. Moreover, a combination of structural and biophysical studies
showed that two CaMmolecules bind to Fas.DD and that both the N- and C-terminal lobes of
CaM are involved. These findings further support the view that Fas.DD unfolding is probably
required for CaM binding [52].
Taken together all these literature data provide the basis to hypothesize that binding of CaM
to FADD or TRADD should result in conformational changes of both CaM and its targets.
In vitro oxidation of CaMmethionines drastically reduces CaM affinity for
FADD and TRADD
CaM interacts with both FADD [8] and TRADD (this report). Two putative binding sites were
identified and characterized respectively in the α-helices 8–9 and 10–11 of FADD.DD [8] and
one binding site in the α-helix 2 of TRADD.DD. To assess the role of CaMmethionine residues
in its interaction to FADD and TRADD we performed binding assays with native (CaMN), oxi-
dized (CaMox), partially (CaMMsrA or CaMMsrB2) or totally repaired (CaMR) CaM protein.
CaM contains no cysteine residues and, under acid conditions, oxidation can be specific for
methionine residues [53]. The in vitro extensive oxidation protocol used here converts all nine
methionine residues of CaM to MetO [26], since, although H2O2 can potentially oxidize a
number of amino acids, the thioether group of methionine is not protonated at low pH and
therefore it can be selectively oxidized [53]. Less extensive oxidation can be achieved by treat-
ing oxidized CaM with MsrA or MsrB2 that produce CaM samples containing
multiple oxiforms.
To study the effect of Msr on oxidized CaM, His-CaMox was incubated with either MsrA or
MsrB2 using DTT as an electron donor in the reduction process. As shown in Fig. 3A, CaMox
migrates slower than CaMN, most likely as a consequence of protein conformational alter-
ations, as previously suggested [26], CaMMsrA and CaMMsrB2 (“partially repaired CaM”) mi-
grate in SDS-PAGE as several bands exhibiting different electrophoretic mobility, intermediate
between that of His-CaMN and His-CaMox. These different species/bands, as previously sug-
gested, most likely correspond to partially and heterogeneously reduced CaM molecules, hav-
ing various combinations of oxidized and reduced methionines, with different conformations
and/or affinities for calcium. Upon oxidation, methionine residues of CaM should be randomly
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Figure 3. Methiones oxidation impairs CaM interaction with FADD and TRADD. A: CaM oxidation
analysis. Coomassie blue stained 15% SDS-PAGE loaded with the indicated Xenopus laevis His-CaM
proteins.B. Schematic representation of GST-FADD and GST-TRADD proteins used in pull-down assays.
The DED, DD and the S194 phosphorylation site of human FADD are indicated.C: GST pull-down assays.
The indicated GST proteins bound to gluathione-sepharose beads were incubated with recombinant His-
CaM proteins, as indicated; 50% of the eluted proteins were subjected to SDS-PAGE (12%) and western blot
analysis. I indicates the input of the CaM proteins used in binding assays. The data shown are representative
of at least three independent experiments.
doi:10.1371/journal.pone.0116251.g003
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converted to either the S or the R diastereoisomer of MetO and MsrA or MsrB2 could reduce
only one of the two diastereoisomer [26]. Complete repair of methionine residues of CaMox
was achieved upon incubation with both MsrA and MsrB2. The resulting CaMR, “fully repaired
CaM”, migrates like CaMN on SDS-PAGE suggesting that all nine MetO have been reduced
(Fig. 3A). Next, pull-down assays were performed and the results clearly indicated that oxida-
tion of methionine residues dramatically impairs CaM interaction with FADD, TRADD and
FADD deletions mutants (schematically depicted in Fig. 3B) containing a single CaM binding
site (Fig. 3C). Moreover, CaMMsrA and CaMMsrB2 do not bind or bind weakly to FADD and
TRADD, indicating that incomplete reduction of oxidized CaM by either MsrA or MsrB2 is in-
sufficient to fully restore the interaction (Fig. 3C). Instead, CaMR fully recovers the potency of
native untreated CaM in GST-FADD and GST-TRADD binding (Fig. 3C). Similar results were
obtained by blot overlay experiments, where biotinylated His-CaMN and His-CaMR decorated
filters containing GST-FADD and GST-TRADD, while no signals were detected with His-
CaMox (data not shown).
N- and C-terminal methionine residues of CaM are critical for CaM
binding to FADD and TRADD
The role of the N- and C-terminal methionine-rich patches of CaM in FADD and TRADD
binding was examined using a series of Met-to-Leu CaMmutants, schematically represented in
Table 1 and previously described [34]. Mutation of Met-to-Leu is considered a conservative
substitution based on data from evolution and the physico-chemical properties of the two
amino acids. Throughout evolution, leucine is the most common substitution for methionine
[54]. Leucine is slightly more hydrophobic than methionine, but both amino acids have similar
volumes and propensity to form α-helices. Met-to-Leu substitutions are generally well tolerated
by CaM. We previously used circular dichroism to assess the impact of Met-to-Leu mutations
in CaM and found that up to 5 substitutions had no significant effect on the α-helical content
of the molecule. Substitution of 6 or 9 methionine residues resulted in only a minor loss of α-
helical content. Further, replacement of up to 6 methionines with leucines did not change
CaM’s thermal stability [34]. Met-to-Leu CaMmutants were incubated with GST, GST-FADD
and GST-TRADD and binding was detected by western blot with a CaM polyclonal antibody
that recognizes all CaMmutants (Fig. 4). The binding assays showed that CaM mutants 9L, 8L
109M, 8L 124M, M36/76-145L do not bind FADD or TRADD (Table 2), suggesting that leu-
cine is unable to substitute for methionine in mediating high affinity binding. All other CaM
mutants bind specifically to both proteins (Fig. 4B, Table 2). It is likely that the CaMMet-to-
Leu mutants that bind FADD and TRADD do so via the methionine residues remaining in the
non-mutated either N- or C-terminal lobe. Specifically, the finding that the CaMmutant M36-
76L binds to FADD and TRADD indicates that the C-terminal lobe mediates the interaction.
The preserved competence of CaMmutant M124-145L allows to conclude that binding could
also occur via the N-terminal lobe of CaM. Moreover, the inability of M36/76-145L CaMmu-
tant to bind suggests that the remaining 3 N-terminal lobe methionine residues are insufficient
to maintain binding. Based on these data, it was expected that oxidation of the remaining me-
thionine residues in either the N- or C-terminal lobe of CaM should abolish CaM binding.
Thus, wild-type and Met-to-Leu CaMmutants, that bind FADD and TRADD, were oxidized
and tested for their ability to bind FADD and TRADD. SDS-PAGE and western blot analysis
showed that all oxidized CaMmutants migrate slower than the corresponding native mutants
and are recognized by a CaM polyclonal antibody (Fig. 4B). Native and CaM oxidized mutants
were then used in binding assays with FADD and TRADD. As shown in Fig. 4B, oxidation
abolishes CaM binding to TRADD and FADD, while, in the same experimental conditions, the
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native CaM mutants bind both proteins. The results with the oxidized CaMMet-to-Leu mu-
tants further support the suggestion that methionine residues in both the N- and C-terminal
lobes of CaM are critical for the interaction. Notably, both the N- and C-terminal lobes of CaM
have been shown to be important for Fas.DD interaction [52].
Protein conformational plasticity of CaM has been proposed as a means of achieving func-
tional diversity [17]. Plasticity of CaM at the level of individual amino acid side chains, in par-
ticular methionine residues, and in terms of orientation of the N- and C-terminal lobes is
crucial for recognition and regulation of more than three hundred CaM targets [16, 17]. CaM
contains nine methionines corresponding to 6% of the entire sequence, which is significantly
higher than the average of known proteomes (1%). The relevance of methionines in interacting
with target proteins has emerged from a number of structures of CaM in complex with its tar-
gets, where CaM can adopt largely different conformations [17]. Proteins that interact with a
large number of partners play a central role in the organization of protein interaction networks
[55]. Interestingly, CaM protein has been shown to undergo post-translational modifications
Figure 4. Effect of Met-to-Leu substitutions in CaM on FADD and TRADD binding. A: CaMmutants and
SDS-PAGE analysis. Coomassie stained gel (a) and western blot analysis (b) of CaMmutants, identified by a
numerical code detailed in Table 1. B: GST pull-down assays. Native (N) or oxidized (Ox) CaMmutants were
incubated with the indicated GST proteins bound to glutathione-sepharose beads. 50% of the eluted proteins
were analyzed by 12% SDS-PAGE and blotted to nitrocellulose stained with ponceau (a) and processed for
western blot (b). I indicates the input of recombinant CaM proteins (250 ng). CaMmutants are identified by a
numerical code as in Table 1. A andB: the black vertical lines in all panels indicate that non-adjacent lanes
from the same gel or blots are shown. The data shown are representative of three independent experiments.
doi:10.1371/journal.pone.0116251.g004
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including acetylation, trimethylation, carboxylmethylation, proteolytic cleavage, and phos-
phorylation and to be highly susceptible to methionine oxidation. Indeed, oxidized CaM has
been isolated from nitric oxide synthase isoforms of aged animals [56, 57]. Overall, the litera-
ture data clearly indicate that methionine residues are important for CaM binding and that
CaM functions can be modulated by the redox status of its methionine residues: oxidation
could lower CaM affinity for calcium [33], could impair directly or indirectly targets recogni-
tion [21–32] and/or increase CaM susceptibility to degradation by the proteasome [34–36].
For example, oxidized CaM is unable to properly activate the plasma membrane Ca2+-ATPase
[22–25], the Bordetella pertussis adenylate cyclase [26], the ryanodine receptor calcium channel
RyR1 and RyR2 [27–28] and some protein kinases [30, 31].
Oxygen radicals and other reactive oxygen species (ROS) may lead to damage of nucleic
acids, lipids and proteins [58], but can also modulate cell signaling, gene expression, cell death,
cell cycle, proliferation and cell differentiation [59–62]. This dual function of ROS, due proba-
bly to differences in local concentrations, pulse duration and sub-cellular localization, is main-
tained through a delicate balance between production and removal of oxidants using both
enzymatic and non-enzymatic processes. Cysteine and methionine amino acids are very sensi-
tive to oxidation by ROS. The damage of most oxidized proteins is non-repairable, and has
consequences on protein structure and function, although certain oxidation products of cyste-
ine and methionine can be repaired [63, 64]. The major fate of unrepaired oxidized proteins is
catabolism by proteosomal pathways to avoid their toxic accumulation within cells [65].
Our results suggest that in vivo oxidation of CaM could alter CaM binding to TRADD and
FADD and in turn regulate FADD and TRADD functions.
Conclusions
The majority of literature data in the last decade on death-domain proteins concern biochemi-
cal and functional studies on homotypic interactions [66]. The crystal structures of multimeric
DD complexes, such as PIDDosome [67] Fas-FADD [48], MyDDosome [68], RIPoptosome
[69], demonstrate that a single DD can engage in up to six interactions through three distinct
and well-defined interaction types involving different helix/loop combinations in the interact-
ing DDs. Little is known about the mechanisms regulating dynamic DD complex assembly in
response to extracellular and intracellular changes including protein concentration, compart-
mentalization, protein folding and post-translational modifications. The interaction of DD
proteins with CaM can modulate signaling pathways mediated or not by multimeric complexes
[8–10]. Roles of TRADD-CaM interaction in death receptors signaling or death independent
functions remain to be determined. Interestingly, TRADDmutants that impair CaM binding
can still mediate interaction of TRADD with DD partners, such as TNFR1 and FADD, and
Table 2. Binding assays of Met-to-Leu CaM mutants.
Code Description GST GST-FADD GST-TRADD
1 wild type − + +
2 9L − − −
3 8L 109M − − −
4 8L 124M − − −
5 M36–76L − + +
6 M124–145L − + +
7 M51–72L − + +
8 M36/76–145L − − −
doi:10.1371/journal.pone.0116251.t002
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thus could be instrumental to investigate the impact of CaM on TRADD-dependent
complexes assembly.
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